Skip to content
Create startup

New Owner

Pfizer - BIND Therapeutics

Pfizer acquires BIND Therapeutics

Announced: July 27, 2016

Type:           Acquisition
Status:         Complete

Amount:       $ 40,000,000

Acquisition News

Add News

Date Title
Jul 29, 2016 benchmarkmonitor.com - Pfizer Inc. (NYSE:PFE) Cleared to Buy Nanotech Drug Firm BIND Therapeutics (NASDAQ:BIND): American Express Company (NYSE:AXP), Merck & Co. Inc. (NYSE:MRK)
Pfizer Inc. (NYSE:PFE) Cleared to Buy Nanotech Drug Firm BIND Therapeutics (NASDAQ:BIND): American Express Company (NYSE:AXP), Merck & Co. Inc. (NYSE:MRK)
Jul 26, 2016 ir.bindtherapeutics.com - BIND Therapeutics Determines Pfizer's $40 Million Bid Is Highest and Best in 363 Auction for Substantially All of BIND's Assets
BIND Therapeutics Determines Pfizer's $40 Million Bid Is Highest and Best in 363 Auction for Substantially All of BIND's Assets
Jul 26, 2016 Yahoo Finance - BIND Therapeutics Determines Pfizer’s $40 Million Bid Is Highest and Best in 363 Auction for Substantially All of BIND’s Assets
BIND Therapeutics Determines Pfizer’s $40 Million Bid Is Highest and Best in 363 Auction for Substantially All of BIND’s Assets

Pfizer Other Acquisitions

Add Acquisition

Date Acquired Amount
Aug 24, 2016
AstraZeneca - molecule antibiotics
AstraZeneca - molecule antibiotics
 $ 1,500,000,000
Aug 22, 2016
Medivation
Medivation
 $ 14,000,000,000
Aug 01, 2016
Bamboo Therapeutics
Bamboo Therapeutics
 $ 654,000,000
May 16, 2016
Anacor Pharmaceutical
Anacor Pharmaceutical
 $ 5,200,000,000
Nov 23, 2015
Allergan
Allergan
 $ 160,000,000,000
View more acquisitions »